Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,789,412
-
Total 13F shares
-
87,976,058
-
Share change
-
+503,081
-
Total reported value
-
$276,403,640
-
Put/Call ratio
-
18%
-
Price per share
-
$3.14
-
Number of holders
-
123
-
Value change
-
-$879,364
-
Number of buys
-
57
-
Number of sells
-
54
Institutional Holders of ACELYRIN, Inc. - Common Stock (SLRN) as of Q4 2024
As of 31 Dec 2024,
ACELYRIN, Inc. - Common Stock (SLRN) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,976,058 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., AyurMaya Capital Management Company, LP, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, venBio Partners LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and Blue Owl Capital Holdings LP.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.